Physiology May Be the Key: Cardiovascular Risk Stratification in Obstructive Sleep Apnea

Abstract

a JA, Eddahibi S, Flores SC, Grimminger F, et al. Inflammation, growth factors, and pulmonary vascular remodeling. J Am Coll Cardiol 2009; 54(Suppl):S10–S19. 3. Morrell NW, Adnot S, Archer SL, Dupuis J, Lloyd Jones P, MacLean MR, et al. Cellular and molecular basis of pulmonary arterial hypertension. J Am Coll Cardiol 2009; 54(Suppl)S20–S31. 4. Rawal H, Suman A, Bhoite RR, Kanwal A, Young RK, Aronow WS, et al. Anticoagulation in pulmonary arterial hypertension: do we know the answer? Curr Probl Cardiol 2021;46:100738. 5. Lang I. Chronic thromboembolic pulmonary hypertension: a distinct disease entity. Eur Respir Rev 2015;24:246–252. 6. Polytarchou K, Varvarousis D, Manolis AS. Cardiovascular disease in antiphospholipid syndrome. Curr Vasc Pharmacol 2020;18:538–548. 7. Alba GA, Samokhin AO, Wang R-S, Zhang Y-Y, Wertheim BM, Arons E, et al. NEDD9 is a novel and modifiable mediator of platelet–endothelial adhesion in the pulmonary circulation. Am J Respir Crit Care Med 2021;203:1533–1545. 8. Delaney C, Davizon-Castillo P, Allawzi A, Posey J, Gandjeva A, Neeves K, et al. Platelet activation contributes to hypoxia-induced inflammation. Am J Physiol Lung Cell Mol Physiol 2021:320:L413–L421. 9. Middleton EA, Weyrich AS, Zimmerman GA. Platelets in pulmonary immune responses and inflammatory lung diseases. Physiol Rev 2016;96:1211–1259. 10. Lam FW, Vijayan KV, Rumbaut RE. Platelets and their Interactions with other immune cells. Compr Physiol 2015;5:1265–1280. 11. Vemana HP, Karim ZA, Conlon C, Khasawneh FT. A critical role for the transient receptor potential channel type 6 in human platelet activation. PLoS One 2015;10:e0125764. 12. Mahaut-Smith MP, Taylor KA, Evans RJ. Calcium signalling through ligand-gated ion channels such as P2X1 receptors in the platelet and other non-excitable cells. Adv Exp Med Biol 2016;898: 305–329. 13. Silva-Rojas R, Laporte J, B€ ohm J. STIM1/ORAI1 loss-of-function and gain-of-function mutations inversely impact on SOCE and calcium homeostasis and cause multi-systemic mirror diseases. Front Physiol 2020;11:604941. 14. Borst O, Schmidt EM, M€ unzer P, Sch€ onberger T, Towhid ST, Elvers M, et al. The serumand glucocorticoid-inducible kinase 1 (SGK1) influences platelet calcium signaling and function by regulation of Orai1 expression in megakaryocytes. Blood 2012;119:251–261. 15. Varga-Szabo D, Braun A, Nieswandt B. Calcium signaling in platelets. J Thromb Haemost 2009;7:1057–1066. 16. Offermanns S. Activation of platelet function through G protein-coupled receptors. Circ Res 2006;99:1293–1304. 17. Ilkan Z, Wright JR, Goodall AH, Gibbins JM, Jones CI, Mahaut-Smith MP. Evidence for shear-mediated Ca entry through mechanosensitive cation channels in human platelets and a megakaryocytic cell line. J Biol Chem 2017;292:9204–9217. 18. Wang J, Xu C, Zheng Q, Yang K, Lai N, Wang T, et al. Orai1, 2, 3 and STIM1 promote store-operated calcium entry in pulmonary arterial smooth muscle cells. Cell Death Discov 2017;3:17074. 19. Wang J, Weigand L, Lu W, Sylvester JT, Semenza GL, Shimoda LA. Hypoxia inducible factor 1 mediates hypoxia-induced TRPC expression and elevated intracellular Ca in pulmonary arterial smooth muscle cells. Circ Res 2006;98:1528–1537. 20. He X, Song S, Ayon RJ, Balisterieri A, Black SM, Makino A, et al. Hypoxia selectively upregulates cation channels and increases cytosolic [Ca] in pulmonary, but not coronary, arterial smooth muscle cells. Am J Physiol Cell Physiol 2018;314:C504–C517. 21. Samokhin AO, Stephens T, Wertheim BM, Wang RS, Vargas SO, Yung LM, et al. NEDD9 targets COL3A1 to promote endothelial fibrosis and pulmonary arterial hypertension. Sci Transl Med 2018;10:eaap7294. 22. Samokhin AO, Hsu S, Yu PB, Waxman AB, Alba GA, Wertheim BM, et al. Circulating NEDD9 is increased in pulmonary arterial hypertension: a multicenter, retrospective analysis. J Heart Lung Transplant 2020;39:289–299.